StockWatch
·
Pharmaceuticals
Insider Trading28 Sept 2026, 05:41 pm

Sanofi Consumer Healthcare India Ltd Closes Trading Window for Q3 FY27 Results

AI Summary

Sanofi Consumer Healthcare India Ltd has announced the closure of its trading window for designated persons. This closure is in anticipation of the declaration of Unaudited Standalone Financial Results for the quarter and nine months ended September 30, 2026. The trading window will be shut from October 1, 2026, and will reopen 48 hours after the results are officially announced to the stock exchanges. This measure is in line with the company's Code of Conduct to prevent insider trading.

Key Highlights

  • Trading window closed for declaration of Q3 FY27 financial results.
  • Closure effective from October 1, 2026.
  • Window reopens 48 hours post-results announcement.
  • Measures to prevent insider trading are in place.